South Korea

SAMIK PHARM. (014950)

Track

Track

SAMIK PHARM. recorded one notable insider transaction over the past ninety days. An unclassified executive, Kwon Young Ee, sold 20,000 shares valued at 220 million KRW on September 17, 2026. This divestment represents the sole activity during this period, occurring amidst an 8.1% stock price increase, while the equity remains significantly below its annual peak.
Ticker: 014950 Exchange: KOSDAQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
KWON YOUNG EE (권영이) Unclassified position (각자 대표이사) Executive Director
Transaction date
Sale
Price
475.69
Quantity 32,946 -35.5%
Value ₩2,730,384
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-23 2026-09-17 S Sale KWON YOUNG EE (권영이)

Unclassified position (각자 대표이사)

Executive Director
32,946 -35.5%
475.69
₩2,730,384 		32,946 -35.5% 475.69 ₩2,730,384
Explore more

More insider trading research around SAMIK PHARM.

More insider trades in South Korea
Insider trading in Asia-Pacific